Loading…
Metabolism of endothelin‐1 and big endothelin‐1 by recombinant neutral endopeptidase EC.3.4.24.11
1 Inhibitors of neutral endopeptidase EC.3.4.24.11 (NEP) have been shown to attenuate the hypertensive effect of big‐endothelin‐1 (BET‐1) in rats. To determine whether NEP converts BET‐1 to endothelin‐1 (ET‐1), the effect of a recombinant NEP (rNEP) on BET‐1 and on ET‐1 was assessed in vitro. 2 Incu...
Saved in:
Published in: | British journal of pharmacology 1993-08, Vol.109 (4), p.1024-1028 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | 1
Inhibitors of neutral endopeptidase EC.3.4.24.11 (NEP) have been shown to attenuate the hypertensive effect of big‐endothelin‐1 (BET‐1) in rats. To determine whether NEP converts BET‐1 to endothelin‐1 (ET‐1), the effect of a recombinant NEP (rNEP) on BET‐1 and on ET‐1 was assessed in vitro.
2
Incubation of [125I]‐ET‐1 with 1 μg ml−1 of rNEP resulted in degradation of the peptide within minutes. Increase in the amount of rNEP to 10 μg ml−1 led to total cleavage of [125I]‐ET‐1 within seconds.
3
Phosphoramidon (10 μm) or SQ‐28,603 (100 μm) totally suppressed the degradation of [125I]‐ET‐1 by rNEP.
4
The degradation of [125I]‐BET‐1 by either 1 or 10 μg ml−1 of rNEP was much slower than that of [125I]‐ET‐1. Again, both phosphoramidon and SQ 28,603 protected the peptide from degradation.
5
Intact [125I]‐ET‐1 was not observed when [125I]‐BET‐1 was incubated with rNEP.
6
These data show that neutral endopeptidase EC.3.4.24.11 is not an endothelin converting enzyme. |
---|---|
ISSN: | 0007-1188 1476-5381 |
DOI: | 10.1111/j.1476-5381.1993.tb13724.x |